Biotech Firm PLUS THERAPEUTICS Ready for Public Trading Following SEC Approval

Rhea-AI Filing Summary

The Securities and Exchange Commission has declared Plus Therapeutics' Form S-1 registration statement effective as of June 23, 2025, at 9:00 A.M. The registration statement was filed under File Number 333-288121.

A Form S-1 is a crucial SEC filing used for registering new securities offerings with the SEC. This effectiveness notice indicates that Plus Therapeutics has completed the registration process and received regulatory approval to proceed with their planned securities offering.

This development is significant for investors as it typically precedes:

• A new public offering of securities
• The ability to begin selling registered securities to the public
• Potential changes in the company's capital structure

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 23, 2025 9:00 A.M.

Form:

S-1

CIK:	0001095981
Company Name:	PLUS THERAPEUTICS, INC.
File Number:	333-288121

FAQ

When did PSTV's S-1 registration statement become effective?

PSTV's S-1 registration statement became effective on June 23, 2025 at 9:00 A.M., as declared by the Securities and Exchange Commission.

What is PSTV's CIK number on the S-1 filing?

PLUS THERAPEUTICS, INC.'s CIK (Central Index Key) number is 0001095981 as shown on the S-1 registration statement.

What is the file number for PSTV's S-1 registration statement?

The file number for PLUS THERAPEUTICS' S-1 registration statement is 333-288121.

When was PSTV's S-1 effectiveness notice filed with the SEC?

The notice of effectiveness for PSTV's S-1 registration statement was filed with the SEC on June 28, 2025.